Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
May 24, 2010
Finance
Normalizing oxygen
...Osaka: 4508), following the merger of the Mitsubishi Pharma subsidiary of Mitsubishi Chemical Holdings with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Feb 16, 2009
Clinical News
Avanafil: Phase III started
...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Dec 22, 2008
Clinical News
Avanafil: Phase III started
...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Dec 3, 2007
Company News
Genelabs, Mitsubishi Tanabe Pharma deal
...another Phase III trial in April (see BioCentury, April 9). The original deal was with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Oct 8, 2007
Company News
Mitsubishi Chemical Holdings Corp., Tanabe Seiyaku deal
...Mitsubishi Tanabe Pharma Corp. (see BioCentury, Feb. 12). Mitsubishi Chemical Holdings Corp. (Tokyo:4188), Tokyo, Japan
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Oct 1, 2007
Company News
Ista, Tanabe Seiyaku deal
...Mitsubishi Pharma Corp. (Tokyo, Japan) (see BioCentury, Feb. 12). Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Aug 13, 2007
Product Development
Speedy delivery
...Speedy delivery Company Product Delivery Status Earliest analgesic effect Cephalon/
Tanabe Seiyaku
Actiq fentanyl Buccal Mkt Label: Actiq...
Read More
BioCentury
|
Jun 4, 2007
Company News
Medarex, Mitsubishi Pharma deal
...partners will share responsibilities for research. Further terms were not disclosed. Mitsubishi is merging with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
May 14, 2007
Clinical News
Bepotastine: Preliminary Phase II/III data
...last year. Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Senju Pharmaceutical Co. Ltd. , Osaka, Japan
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
May 9, 2007
Clinical News
Ista reports Phase II/III allergic conjunctivitis data
...redness. Senju (Osaka, Japan) has exclusive worldwide rights to bepotastine, excluding certain Asian countries, from
Tanabe Seiyaku
...
Read More
Items per page:
10
1 - 10 of 93
BioCentury
|
May 24, 2010
Finance
Normalizing oxygen
...Osaka: 4508), following the merger of the Mitsubishi Pharma subsidiary of Mitsubishi Chemical Holdings with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Feb 16, 2009
Clinical News
Avanafil: Phase III started
...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Dec 22, 2008
Clinical News
Avanafil: Phase III started
...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Dec 3, 2007
Company News
Genelabs, Mitsubishi Tanabe Pharma deal
...another Phase III trial in April (see BioCentury, April 9). The original deal was with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Oct 8, 2007
Company News
Mitsubishi Chemical Holdings Corp., Tanabe Seiyaku deal
...Mitsubishi Tanabe Pharma Corp. (see BioCentury, Feb. 12). Mitsubishi Chemical Holdings Corp. (Tokyo:4188), Tokyo, Japan
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Oct 1, 2007
Company News
Ista, Tanabe Seiyaku deal
...Mitsubishi Pharma Corp. (Tokyo, Japan) (see BioCentury, Feb. 12). Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif.
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
Aug 13, 2007
Product Development
Speedy delivery
...Speedy delivery Company Product Delivery Status Earliest analgesic effect Cephalon/
Tanabe Seiyaku
Actiq fentanyl Buccal Mkt Label: Actiq...
Read More
BioCentury
|
Jun 4, 2007
Company News
Medarex, Mitsubishi Pharma deal
...partners will share responsibilities for research. Further terms were not disclosed. Mitsubishi is merging with
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
May 14, 2007
Clinical News
Bepotastine: Preliminary Phase II/III data
...last year. Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Senju Pharmaceutical Co. Ltd. , Osaka, Japan
Tanabe Seiyaku Co. Ltd.
...
Read More
BioCentury
|
May 9, 2007
Clinical News
Ista reports Phase II/III allergic conjunctivitis data
...redness. Senju (Osaka, Japan) has exclusive worldwide rights to bepotastine, excluding certain Asian countries, from
Tanabe Seiyaku
...
Read More
Items per page:
10
1 - 10 of 93
Previous page
Next page